These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4117276)

  • 1. Synergistic immunosuppressive action of antithymocyte antisera and thymectomy in the human.
    Pirofsky B; Reid RR; Ramirez-Mateos JC; Bardana EJ; August A
    Clin Exp Immunol; 1972 Sep; 12(1):89-101. PubMed ID: 4117276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithymocyte antiserum effects in man.
    Pirofsky B; Beaulieu R; Bardana EJ; August A
    Am J Med; 1974 Mar; 56(3):290-6. PubMed ID: 4130597
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thymectomy and immunosuppression in myasthenia gravis: a prospective study].
    Sandmann MC; Gorz AM; Gracia CM; Batista RJ; Seixas RR; Bittencourt PR
    Arq Neuropsiquiatr; 1990 Mar; 48(1):44-8. PubMed ID: 2378574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Problems posed by the use of anti-thymocyte globulins in myasthenia (apropos of the treatment of 2 cases of myasthenia gravis)].
    Pollini J; Murisasco A; Serratrice G
    Mars Med; 1972; 109(6):395-407. PubMed ID: 4538918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic aspects of the pathogenesis and treatment of myasthenia].
    Lobzin VS; Golovkin VI; Chalov IuV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1006-11. PubMed ID: 225910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of antithymocyte globulin in myasthenia gravis.
    Barnes AD
    Postgrad Med J; 1976; 52(5 Suppl):110-1. PubMed ID: 1087016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.
    Melms A; Malcherek G; Gern U; Sommer N; Weissert R; Wiethölter H; Bühring HJ
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):46-51. PubMed ID: 8094093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithymocyte antiserum therapy in myasthenia gravis.
    Pirofsky B; Reid RH; Bardana EJ; Baker RL
    Postgrad Med J; 1976; 52(5 Suppl):112-7. PubMed ID: 1087017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis therapy in myasthenia gravis.
    Dau PC
    Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis treated with purified antithymocyte antiserum.
    Pirofsky B; Reid RH; Bardana EJ; Baker RL
    Neurology; 1979 Jan; 29(1):112-6. PubMed ID: 311448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 16. [Usefulness of plasmapheresis before thymectomy in the management of myasthenia gravis].
    Iváñez V; Díez-Tejedor E; Lara M; Barreiro P
    Neurologia; 1994; 9(7):277-81. PubMed ID: 7946422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithymocyte antisera globulin effect on human lymphoid neoplasia.
    Pirofsky B; Beaulieu R; Goldman RD
    Arch Intern Med; 1973 Aug; 132(2):171-4. PubMed ID: 4198179
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of myasthenia gravis].
    Jerusalem F
    Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphoid depletion and immunosuppression after thymectomy in the young pig.
    Binns RM; McFarlin DE; Sugar JR
    Nat New Biol; 1972 Aug; 238(84):181-3. PubMed ID: 4559281
    [No Abstract]   [Full Text] [Related]  

  • 20. Individualization of recipient immunosuppression by use of in vitro monitoring parameters.
    Thomas F; Thomas J; Mendez G; Lee HM; Lower R
    Transplant Proc; 1978 Sep; 10(3):621-5. PubMed ID: 362647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.